Virus/Allergen Interactions and Exacerbations of Asthma

Immunology and Allergy Clinics of North America

Volumn 30, Issue 4, 2010, Pages 553-563

  Kloepfer, Kirsten M ^a   Gern, James E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Allergic sensitization; Asthma; Viral induced wheezing

Indexed keywords

ALLERGEN; CORTICOSTEROID; MONTELUKAST; OMALIZUMAB;

ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL RESEARCH; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HUMAN RHINOVIRUS; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHINOVIRUS INFECTION; RISK FACTOR; SENSITIZATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IMMUNITY; WHEEZING;

ASTHMA; HUMANS; HYPERSENSITIVITY; VIRUS DISEASES;

EID: 77958501828     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2010.08.002     Document Type: Review

References (61)

1. Martinez F.D., Wright A.L., Taussig L.M., et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995, 332(3):133-138.
2. Olenec J.P., Kim W.K., Lee W.M., et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010, 125(5):1001-1006.
3. Sigurs N., Bjarnason R., Sigurbergsson F., et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161(5):1501-1507.
4. Stein R.T., Sherrill D., Morgan W.J., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354(9178):541-545.
5. Johnston S.L., Pattemore P.K., Sanderson G., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310(6989):1225-1229.
6. Johnston N.W., Johnston S.L., Duncan J.M., et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005, 115(1):132-138.
7. Johnston N.W., Johnston S.L., Norman G.R., et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006, 117(3):557-562.
8. Holt P.G., Rowe J., Kusel M., et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol 2010, 125(3):653-659.
9. Sears M.R., Burrows B., Flannery E.M., et al. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991, 325(15):1067-1071.
10. Peat J.K., Toelle B.G., Dermand J., et al. Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy 1996, 51(11):804-810.
11. Illi S., von M.E., Lau S., et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006, 368(9537):763-770.
12. Kusel M.M., de Klerk N.H., Kebadze T., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007, 119(5):1105-1110.
13. Jackson D.J., Gangnon R.E., Evans M.D., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008, 178(7):667-672.
14. Duff A.L., Pomeranz E.S., Gelber L.E., et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993, 92(4):535-540.
15. Rakes G.P., Arruda E., Ingram J.M., et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999, 159(3):785-790.
16. Murray C.S., Poletti G., Kebadze T., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006, 61(5):376-382.
17. Green R.M., Custovic A., Sanderson G., et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002, 324(7340):763.
18. Rosenstreich D.L., Eggleston P., Kattan M., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997, 336(19):1356-1363.
19. Gern J.E., Calhoun W., Swenson C., et al. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997, 155(6):1872-1876.
20. Mosser A.G., Vrtis R., Burchell L., et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005, 171(6):645-651.
21. Papadopoulos N.G., Bates P.J., Bardin P.G., et al. Rhinoviruses infect the lower airways. J Infect Dis 2000, 181(6):1875-1884.
22. Calhoun W.J., Dick E.C., Schwartz L.B., et al. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994, 94:2200-2208.
23. Avila P.C., Abisheganaden J.A., Wong H., et al. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 2000, 105(5):923-932.
24. De Kluijver J., Evertse C.E., Sont J.K., et al. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure?. Am J Respir Crit Care Med 2003, 168:1174-1180.
25. DeMore J.P., Weisshaar E.H., Vrtis R.F., et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 2009, 124(2):245-252.
26. Fleming H.E., Little F.F., Schnurr D., et al. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999, 160(1):100-108.
27. Message S.D., Laza-Stanca V., Mallia P., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 2008, 105(36):13562-13567.
28. Copenhaver C.C., Gern J.E., Li Z., et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 2004, 170:175-180.
29. Gern J.E., Brooks G.D., Meyer P., et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 2006, 117:72-78.
30. Rosenthal L.A., Mikus L.D., Tuffaha A., et al. Attenuated innate mechanisms of interferon-gamma production in rats susceptible to postviral airway dysfunction. Am J Respir Cell Mol Biol 2004, 30(5):702-709.
31. Heaton T., Rowe J., Turner S., et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005, 365(9454):142-149.
32. Holt P.G., Upham J.W., Sly P.D. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005, 116(1):16-24.
33. Stern D.A., Guerra S., Halonen M., et al. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 2007, 120(4):835-841.
34. Isaacs D., Clarke J.R., Tyrrell D.A., et al. Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet 1981, 2(8253):950-952.
35. Parry D.E., Busse W.W., Sukow K.A., et al. Rhinovirus-induced peripheral blood mononuclear cell responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 2000, 105:692-698.
36. Gern J.E., Vrtis R., Grindle K.A., et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000, 162:2226-2231.
37. Bufe A., Gehlhar K., Grage-Griebenow E., et al. Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol 2002, 127(1):82-88.
38. Gehlhar K., Bilitewski C., Reinitz-Rademacher K., et al. Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy 2006, 36(3):331-337.
39. Papadopoulos N.G., Stanciu L.A., Papi A., et al. Rhinovirus-induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects. Clin Exp Allergy 2002, 32(4):537-542.
40. Contoli M., Message S.D., Laza-Stanca V., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12(9):1023-1026.
41. Wark P.A., Johnston S.L., Bucchieri F., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201(6):937-947.
42. Bochkov Y.A., Hanson K.M., Keles S., et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2010, 3:69-80.
43. Lopez-Souza N., Favoreto S., Wong H., et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 2009, 123(6):1384-1390.
44. Caproni M., Antiga E., Torchia D., et al. FoxP3-expressing T regulatory cells in atopic dermatitis lesions. Allergy Asthma Proc 2007, 28(5):525-528.
45. Smyth L.J., Eustace A., Kolsum U., et al. Increased airway T regulatory cells in asthmatic subjects. Chest 2010, [Epub ahead of print]. DOI:10.1378/chest.09-3079.
46. Benoit L.A., Holtzman M.J. New immune pathways from chronic post-viral lung disease. Ann N Y Acad Sci 2010, 1183:195-210.
47. Subrata L.S., Bizzintino J., Mamessier E., et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009, 183(4):2793-2800.
48. Roponen M., Yerkovich S.T., Hollams E., et al. Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J 2010, 35(1):64-71.
49. Tversky J.R., Le T.V., Bieneman A.P., et al. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008, 38(5):781-788.
50. Gill M.A., Bajwa G., George T.A., et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 2010, 184(11):5999-6006.
51. Schroeder J.T., Bieneman A.P., Xiao H., et al. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 2005, 175(9):5724-5731.
52. Kato A., Favoreto S., Avila P.C., et al. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007, 179(2):1080-1087.
53. Sakamoto M., Ida S., Takishima T. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J Immunol 1984, 132:2614-2617.
54. Jakiela B., Brockman-Schneider R., Amineva S., et al. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol 2008, 38(5):517-523.
55. Lopez-Souza N., Dolganov G., Dubin R., et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 2004, 286(2):L373-L381.
56. Holgate S.T., Roberts G., Arshad H.S., et al. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc 2009, 6(8):655-659.
57. Lachowicz-Scroggins M.E., Boushey H.A., Finkbeiner W.E., et al. Interleukin-13 induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 2010, [Epub ahead of print]. DOI:10.1165/rcmb.2009-0244OC.
58. Lemanske R.F., Dick E.C., Swenson C.A., et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989, 83(1):1-10.
59. Johnston N.W., Mandhane P.J., Dai J., et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 2007, 120(3):e702-e712.
60. Kim C.K., Choi J., Kim H.B., et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr 2010, 156(5):749-754.
61. Busse W.W., Massanari M., Kianifard F., et al. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis. Curr Med Res Opin 2007, 23(10):2379-2386.